NO180450C - Farmasöytiske formuleringer og fremgangsmåte for fremstilling av form II diritromycin - Google Patents

Farmasöytiske formuleringer og fremgangsmåte for fremstilling av form II diritromycin

Info

Publication number
NO180450C
NO180450C NO921616A NO921616A NO180450C NO 180450 C NO180450 C NO 180450C NO 921616 A NO921616 A NO 921616A NO 921616 A NO921616 A NO 921616A NO 180450 C NO180450 C NO 180450C
Authority
NO
Norway
Prior art keywords
dirithromycin
preparation
pharmaceutical formulations
formulations
tablet containing
Prior art date
Application number
NO921616A
Other languages
English (en)
Norwegian (no)
Other versions
NO921616L (no
NO921616D0 (no
NO180450B (no
Inventor
James Michael Greene
Holly Marie Hankins
Gregory Alan Stephenson
David Dale Wirth
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO921616D0 publication Critical patent/NO921616D0/no
Publication of NO921616L publication Critical patent/NO921616L/no
Publication of NO180450B publication Critical patent/NO180450B/no
Publication of NO180450C publication Critical patent/NO180450C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Formation And Processing Of Food Products (AREA)
NO921616A 1991-04-29 1992-04-27 Farmasöytiske formuleringer og fremgangsmåte for fremstilling av form II diritromycin NO180450C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69284291A 1991-04-29 1991-04-29

Publications (4)

Publication Number Publication Date
NO921616D0 NO921616D0 (no) 1992-04-27
NO921616L NO921616L (no) 1992-10-30
NO180450B NO180450B (no) 1997-01-13
NO180450C true NO180450C (no) 1997-04-23

Family

ID=24782254

Family Applications (2)

Application Number Title Priority Date Filing Date
NO921616A NO180450C (no) 1991-04-29 1992-04-27 Farmasöytiske formuleringer og fremgangsmåte for fremstilling av form II diritromycin
NO921617A NO179504C (no) 1991-04-29 1992-04-27 Legemiddel i form av en tablett inneholdende diritromycin

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO921617A NO179504C (no) 1991-04-29 1992-04-27 Legemiddel i form av en tablett inneholdende diritromycin

Country Status (27)

Country Link
EP (2) EP0511799B1 (fi)
JP (2) JP3135672B2 (fi)
KR (2) KR100193742B1 (fi)
CN (2) CN1069197C (fi)
AT (2) ATE138924T1 (fi)
AU (2) AU655978B2 (fi)
BR (2) BR9201541A (fi)
CA (2) CA2067275C (fi)
CY (2) CY1946A (fi)
CZ (2) CZ282218B6 (fi)
DE (2) DE69214710T2 (fi)
DK (2) DK0511799T3 (fi)
ES (2) ES2088098T3 (fi)
FI (2) FI921876A (fi)
GR (2) GR3020439T3 (fi)
HK (2) HK153696A (fi)
HU (2) HU213613B (fi)
IE (2) IE74885B1 (fi)
IL (2) IL101705A (fi)
MX (2) MX9201946A (fi)
MY (2) MY114226A (fi)
NO (2) NO180450C (fi)
NZ (2) NZ242505A (fi)
RU (2) RU2070203C1 (fi)
TW (2) TW216399B (fi)
YU (2) YU44392A (fi)
ZA (2) ZA922777B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW271400B (fi) * 1992-07-30 1996-03-01 Pfizer
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
ES2173057T3 (es) * 1996-07-29 2004-11-16 Abbott Laboratories Preparacion de la forma ii cristalina de claritromicina.
ID21762A (id) * 1996-09-24 1999-07-22 Lilly Co Eli Formulasi partikel bersaput
US6390690B1 (en) 2000-05-17 2002-05-21 3M Innovative Properties Company Fiber optic connector for coupling devices on intersecting planes
CA2670482C (en) * 2006-12-05 2011-10-11 Pfizer Inc. Motilide polymorphs
CN102145008B (zh) * 2010-12-29 2013-06-05 辰欣药业股份有限公司 一种地红霉素药物组合物及其制备方法
CN107151261B (zh) * 2017-06-09 2020-06-12 广州大光制药有限公司 一种地红霉素化合物的晶型及其结晶制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
DE2515075C2 (de) * 1975-04-07 1985-10-24 Dr. Karl Thomae Gmbh, 7950 Biberach Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
MY114226A (en) 2002-09-30
JPH05117289A (ja) 1993-05-14
AU1525792A (en) 1992-11-05
FI101795B1 (fi) 1998-08-31
EP0511800A1 (en) 1992-11-04
CY1946A (en) 1992-04-27
NO921616L (no) 1992-10-30
AU655978B2 (en) 1995-01-19
KR100193742B1 (ko) 1999-06-15
CA2067275A1 (en) 1992-10-30
RU2070203C1 (ru) 1996-12-10
NO921616D0 (no) 1992-04-27
YU44492A (sh) 1994-06-24
ZA922776B (en) 1993-10-15
HUT63956A (en) 1993-11-29
AU1525592A (en) 1992-11-05
IE76296B1 (en) 1997-10-08
MY109498A (en) 1997-02-28
IL101704A (en) 1998-02-22
YU44392A (sh) 1994-12-28
GR3021706T3 (en) 1997-02-28
DE69214710T2 (de) 1997-03-13
CS127792A3 (en) 1992-11-18
FI921876A0 (fi) 1992-04-27
ZA922777B (en) 1993-10-15
GR3020439T3 (en) 1996-10-31
CZ282218B6 (cs) 1997-06-11
CN1066186A (zh) 1992-11-18
KR920019365A (ko) 1992-11-19
HU213613B (en) 1997-08-28
NO921617L (no) 1992-10-30
HK215096A (en) 1996-12-13
BR9201541A (pt) 1992-12-01
CA2067274A1 (en) 1992-10-30
NZ242506A (en) 1993-09-27
CN1066270A (zh) 1992-11-18
CZ282021B6 (cs) 1997-04-16
MX9201946A (es) 1992-11-01
TW315371B (fi) 1997-09-11
FI921877A0 (fi) 1992-04-27
IE74885B1 (en) 1997-08-13
HU9201398D0 (en) 1992-07-28
JPH05117154A (ja) 1993-05-14
FI921877A (fi) 1992-10-30
CY1975A (en) 1997-09-05
IL101705A (en) 1996-01-31
NZ242505A (en) 1993-06-25
AU646734B2 (en) 1994-03-03
ES2093779T3 (es) 1997-01-01
HK153696A (en) 1996-08-16
CN1069197C (zh) 2001-08-08
IL101704A0 (en) 1992-12-30
CA2067275C (en) 2002-11-26
KR100194307B1 (ko) 1999-06-15
TW216399B (fi) 1993-11-21
CN1030611C (zh) 1996-01-03
CS127692A3 (en) 1992-11-18
CA2067274C (en) 2002-10-15
DE69214710D1 (de) 1996-11-28
KR920019364A (ko) 1992-11-19
MX9201944A (es) 1992-11-01
DE69211220D1 (de) 1996-07-11
DE69211220T2 (de) 1996-11-07
NO180450B (no) 1997-01-13
HU215917B (hu) 1999-03-29
IL101705A0 (en) 1992-12-30
DK0511800T3 (da) 1997-04-21
HUT62595A (en) 1993-05-28
ATE138924T1 (de) 1996-06-15
EP0511799A1 (en) 1992-11-04
FI101795B (fi) 1998-08-31
NO179504C (no) 1996-10-23
EP0511800B1 (en) 1996-10-23
ATE144425T1 (de) 1996-11-15
IE921346A1 (en) 1992-11-04
EP0511799B1 (en) 1996-06-05
NO921617D0 (no) 1992-04-27
JP3333545B2 (ja) 2002-10-15
NO179504B (no) 1996-07-15
FI921876A (fi) 1992-10-30
JP3135672B2 (ja) 2001-02-19
RU2045953C1 (ru) 1995-10-20
BR9201540A (pt) 1992-12-01
IE921345A1 (en) 1992-11-04
DK0511799T3 (da) 1996-06-24
HU9203168D0 (en) 1992-12-28
ES2088098T3 (es) 1996-08-01

Similar Documents

Publication Publication Date Title
IL101795A0 (en) Pharmaceutical tablet formulations
ITRM920237A1 (it) Perfezionato impiego di medicinali broncodilatatori b2.
ITMI921123A0 (it) Formulazioni farmaceutiche orali contenenti antocianosidi
NO180450C (no) Farmasöytiske formuleringer og fremgangsmåte for fremstilling av form II diritromycin
UA15909A1 (uk) Засіб лікуваhhя хроhічhих паhкреатитів
ATE73662T1 (de) Diphosphonsaeurederivat enthaltendes arzneimittel zur oralen gabe.
NO901688D0 (no) Soelvsulfadiazinholdig farmasoeytisk produkt for lokal ekstern terapi.
NO941426D0 (no) Antisporiatiske farmasöytiske preparater og fremgangsmåte for fremstilling av slike
SE9102577D0 (sv) Laekemedel med antidopamineffekt
KR920014777U (ko) 약제 휘산기구
DK7190D0 (da) Laegemiddel
DK524587D0 (da) Laegemiddel
IT8722591A0 (it) Formulazione farmaceutica contenente gemfibrozilmicroincapsulato.